Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells

Zou,Xue; Zhang,Mengxiao; Sun,Yiming; Zhao,Surong; Wei,Yingmei; Zhang,Xudong; Jiang,Chenchen; Liu,Hao

doi:10.3892/or.2015.4147

Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells

Authors:
- Xue Zou
- Mengxiao Zhang
- Yiming Sun
- Surong Zhao
- Yingmei Wei
- Xudong Zhang
- Chenchen Jiang
- Hao Liu
View Affiliations

Affiliations: Faculty of Pharmacy, Bengbu Medical College, Bengbu, Anhui 233004, P.R. China, Priority Research Center for Cancer Research, University of Newcastle, Callaghan, NSW 2308, Australia
Published online on: July 23, 2015 https://doi.org/10.3892/or.2015.4147
Pages: 1895-1904

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumor cells depend on aerobic glycolysis for adenosine triphosphate (ATP) production, which is therefore targeted by therapeutic agents. The compound 3-bromopyruvate (3-BrPA), a strong alkylating agent and hexokinase inhibitor, inhibits tumor cell glycolysis and the production of ATP, causing apoptosis. 3-BrPA induces apoptosis of nasopharyngeal carcinoma (NPC) cell lines HNE1 and CNE-2Z, which may be related to its molecular mechanisms. In the present study, we investigated the effects of 3-BrPA on the viability, reactive oxygen species (ROS), apoptosis and other types of programmed cell death in NPC cells in vitro and in vivo. PI staining showed significant apoptosis in NPC cells accompanied by the overproduction of ROS and downregulation of mitochondrial membrane potential (MMP, ΔΨm) by 3-BrPA. However, the ROS scavenger N-acetyl-L-cysteine (NAC) significantly reduced 3-BrPA-induced apoptosis by decreasing ROS and facilitating the recovery of MMP. We elucidated the molecular mechanisms underlying 3-BrPA activity and found that it caused mitochondrial dysfunction and ROS production, leading to necroptosis of NPC cells. We investigated the effects of the caspase inhibitor z-VAD-fmk, which inhibits apoptosis but promotes death domain receptor (DR)-induced NPC cell necrosis. Necrostatin-1 (Nec-1) inhibits necroptosis, apparently via a DR signaling pathway and thus abrogates the effects of z-VAD‑fmk. In addition, we demonstrated the effective attenuation of 3-BrPA-induced necrotic cell death by Nec-1. Finally, animal studies proved that 3-BrPA exhibited significant antitumor activity in nude mice. The present study is the first demonstration of 3-BrPA-induced non-apoptotic necroptosis and ROS generation in NPC cells and provides potential strategies for developing agents against apoptosis‑resistant cancers.

View Figures

View References

1	Hildesheim A and Levine PH: Etiology of nasopharyngeal carcinoma: A review. Epidemiol Rev. 15:466–485. 1993.PubMed/NCBI
2	Geschwind JF, Ko YH, Torbenson MS, Magee C and Pedersen PL: Novel therapy for liver cancer: Direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 62:3909–3913. 2002.PubMed/NCBI
3	Warburg O: On the origin of cancer cells. Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
4	Nelson K: 3-Bromopyruvate kills cancer cells in animals. Lancet Oncol. 3:5242002. View Article : Google Scholar : PubMed/NCBI
5	Finley RS: Overview of targeted therapies for cancer. Am J Health Syst Pharm. 60:S4–S10. 2003.
6	Mathupala SP, Ko YH and Pedersen PL: Hexokinase-2 bound to mitochondria: Cancer's stygian link to the 'Warburg Effect̓ and a pivotal target for effective therapy. Semin Cancer Biol. 19:17–24. 2009. View Article : Google Scholar :
7	Buchakjian MR and Kornbluth S: The engine driving the ship: Metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol. 11:715–727. 2010. View Article : Google Scholar : PubMed/NCBI
8	Kondoh H: Cellular life span and the Warburg effect. Exp Cell Res. 314:1923–1928. 2008. View Article : Google Scholar : PubMed/NCBI
9	Nakano A, Tsuji D, Miki H, Cui Q, El Sayed SM, Ikegame A, Oda A, Amou H, Nakamura S, Harada T, et al: Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells. PLoS One. 6:e272222011. View Article : Google Scholar : PubMed/NCBI
10	Dolmans DE, Kadambi A, Hill JS, Flores KR, Gerber JN, Walker JP, Borel Rinkes IH, Jain RK and Fukumura D: Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res. 62:4289–4294. 2002.PubMed/NCBI
11	Peter ME: Programmed cell death: Apoptosis meets necrosis. Nature. 471:310–312. 2011. View Article : Google Scholar : PubMed/NCBI
12	Goossens V, Stange G, Moens K, Pipeleers D and Grooten J: Regulation of tumor necrosis factor-induced, mitochondria- and reactive oxygen species-dependent cell death by the electron flux through the electron transport chain complex I. Antioxid Redox Signal. 1:285–295. 1999. View Article : Google Scholar
13	Trachootham D, Lu W, Ogasawara MA, Nilsa RD and Huang P: Redox regulation of cell survival. Antioxid Redox Signal. 10:1343–1374. 2008. View Article : Google Scholar : PubMed/NCBI
14	Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA and Yuan J: Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 1:112–119. 2005. View Article : Google Scholar
15	Declercq W, Vanden Berghe T and Vandenabeele P: RIP kinases at the crossroads of cell death and survival. Cell. 138:229–232. 2009. View Article : Google Scholar : PubMed/NCBI
16	Degterev A, Zhou W, Maki JL and Yuan J: Assays for necroptosis and activity of RIP kinases. Methods Enzymol. 545:1–33. 2014. View Article : Google Scholar : PubMed/NCBI
17	Humphries F, Yang S, Wang B and Moynagh PN: RIP kinases: Key decision makers in cell death and innate immunity. Cell Death Differ. 22:225–236. 2015. View Article : Google Scholar
18	Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B, Adib-Conquy M and Cavaillon JM; Captain Study Group: CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis. J Immunol. 192:2449–2459. 2014. View Article : Google Scholar : PubMed/NCBI
19	Galluzzi L and Kroemer G: Necroptosis: A specialized pathway of programmed necrosis. Cell. 135:1161–1163. 2008. View Article : Google Scholar : PubMed/NCBI
20	Ahmad S and Ansari AA: Therapeutic roles of heparin anticoagulants in cancer and related disorders. Med Chem. 7:504–517. 2011. View Article : Google Scholar : PubMed/NCBI
21	Shoshan MC: 3-Bromopyruvate: Targets and outcomes. J Bioenerg Biomembr. 44:7–15. 2012. View Article : Google Scholar : PubMed/NCBI
22	Cardaci S, Desideri E and Ciriolo MR: Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug. J Bioenerg Biomembr. 44:17–29. 2012. View Article : Google Scholar : PubMed/NCBI
23	Dell'Antone P: Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent. Med Chem. 5:491–496. 2009. View Article : Google Scholar : PubMed/NCBI
24	Scarfò L and Ghia P: Reprogramming cell death: BCL2 family inhibition in hematological malignancies. Immunol Lett. 155:36–39. 2013. View Article : Google Scholar : PubMed/NCBI
25	Ndubaku C, Varfolomeev E, Wang L, Zobel K, Lau K, Elliott LO, Maurer B, Fedorova AV, Dynek JN, Koehler M, et al: Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists. ACS Chem Biol. 4:557–566. 2009. View Article : Google Scholar : PubMed/NCBI
26	Rossé T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B and Borner C: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 391:496–499. 1998. View Article : Google Scholar : PubMed/NCBI
27	Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H, Miyawaki T and Taniguchi N: Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood. 89:1748–1753. 1997.PubMed/NCBI
28	De Flora S, Izzotti A, D'Agostini F and Balansky RM: Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis. 22:999–1013. 2001. View Article : Google Scholar : PubMed/NCBI
29	Wang CC, Liu TY, Cheng CH and Jan TR: Involvement of the mitochondrion-dependent pathway and oxidative stress in the apoptosis of murine splenocytes induced by areca nut extract. Toxicol In Vitro. 23:840–847. 2009. View Article : Google Scholar : PubMed/NCBI
30	de Almagro MC and Vucic D: Necroptosis: Pathway diversity and characteristics. Semin Cell Dev Biol. 39:56–62. 2015. View Article : Google Scholar : PubMed/NCBI
31	Kaczmarek A, Vandenabeele P and Krysko DV: Necroptosis: The release of damage-associated molecular patterns and its physiological relevance. Immunity. 38:209–223. 2013. View Article : Google Scholar : PubMed/NCBI
32	He S, Wang L, Miao L, Wang T, Du F, Zhao L and Wang X: Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 137:1100–1111. 2009. View Article : Google Scholar : PubMed/NCBI
33	Xu X, Chua CC, Kong J, Kostrzewa RM, Kumaraguru U, Hamdy RC and Chua BH: Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem. 103:2004–2014. 2007. View Article : Google Scholar : PubMed/NCBI